Trial Profile
A randomised, placebo-controlled, multi-centre study on the efficacy of Niccine, a vaccine for nicotine, in smoking relapse prevention, assessed in abstinent, adult smokers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2013
Price :
$35
*
At a glance
- Drugs Nicotine abuse vaccine (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- Sponsors Independent Pharmaceutica
- 27 Jul 2011 New trial record